"10.1371_journal.pone.0080313","plos one","2013-11-25T00:00:00Z","Ewa Kotula; Wolfgang Faigle; Nathalie Berthault; Florent Dingli; Damarys Loew; Jian-Sheng Sun; Marie Dutreix; Maria Quanz","Institut Curie, Centre National de Recherche Scientifique (CNRS) UMR3347, Institut National de la Santé et de Recherche Médicale (INSERM) U1021, Université Paris-Sud 11, Centre Universitaire, Orsay, France; DNA Therapeutics, Evry, France; Institut Curie, Centre de Recherche, Laboratory of Proteomic Mass Spectrometry, Paris, France; University Hospital Zürich, Department of Clinical Neuroimmunology and MS Research, Paris, France; Muséum National d’Histoire Naturelle, USM503, Paris, France","Conceived and designed the experiments: MD JSS MQ. Performed the experiments: EK MQ NB WF FD. Analyzed the data: EK WF MD MQ. Contributed reagents/materials/analysis tools: DL JSS. Wrote the paper: EK MD MQ. Developed the mass spectrometry analysis: WF FD DL.","E. Kotula is a recipient of a PhD fellowship cofinanced by DNA Therapeutics and M. Quanz is an employee of DNA Therapeutics. M. Dutreix and J-S. Sun are cofounders of DNA Therapeutics, the company holding the patent for the clinical use of Dbait32Hc. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.","2013","11","Ewa Kotula","EK",8,TRUE,3,5,4,3,TRUE,TRUE,FALSE,0,NA,FALSE
